SCPX:NYE-Scorpius Holdings Inc (USD)

COMMON STOCK | Biotechnology |

Last Closing

USD 0.8

Change

-0.07 (-8.05)%

Market Cap

USD 2.71M

Volume

0.14M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-12 )

Largest Industry Peers for Biotechnology

Symbol Name Price(Change) Market Cap
BHVN Biohaven Pharmaceutical Holdin..

-1.32 (-2.62%)

USD 5.08B
RCUS Arcus Biosciences Inc

-0.34 (-2.03%)

USD 1.44B
NUVB Nuvation Bio Inc

+0.02 (+0.68%)

USD 0.74B
DNA Ginkgo Bioworks Holdings

+0.21 (+2.50%)

USD 0.47B
ANRO Alto Neuroscience, Inc.

+0.03 (+0.67%)

USD 0.37B
ADCT ADC Therapeutics SA

-0.11 (-3.75%)

USD 0.28B
CYBN Cybin Inc

-1.20 (-10.26%)

USD 0.21B
ANVS Annovis Bio Inc

-0.13 (-1.72%)

USD 0.10B
ARMP Armata Pharmaceuticals Inc

-0.03 (-1.09%)

USD 0.10B
PLX Protalix Biotherapeutics Inc

-0.08 (-6.06%)

USD 0.09B

ETFs Containing SCPX

PSI Invesco Dynamic Semicondu.. 3.36 % 0.58 %

-1.22 (0.54%)

N/A
XSD SPDR® S&P Semiconductor .. 3.09 % 0.35 %

-5.24 (0.54%)

N/A
PSCT Invesco S&P SmallCap Info.. 2.92 % 0.29 %

-1.16 (0.54%)

USD 0.30B
PTF Invesco DWA Technology Mo.. 2.67 % 0.60 %

-1.52 (0.54%)

USD 0.46B
LOCK:LSE iShares Digital Security .. 2.04 % 0.00 %

+0.13 (+0.54%)

N/A
IS4S:F iShares Digital Security .. 2.04 % 0.00 %

+0.05 (+0.54%)

N/A
SHLD:LSE iShares IV Public Limited.. 1.89 % 0.00 %

+0.15 (+0.54%)

N/A
DXSN:F Xtrackers - ShortDAX Dail.. 0.00 % 0.00 %

+0.23 (+0.54%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Biotechnology) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 2.71M 4% F 2% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector